{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EGFR L858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper investigates the role of EGFR mutations in lung cancer, focusing on how specific amino acid changes affect kinase activity and downstream signaling pathways.",
      "judgment": "Yes",
      "reasoning": "The study clearly defines the disease mechanism involving EGFR's role in receptor tyrosine kinase signaling and its implication in cancer development."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Enzyme activity assays were employed to measure kinase activity changes caused by EGFR mutations.",
      "judgment": "Yes",
      "reasoning": "The use of enzyme activity assays directly models the disease mechanism by assessing functional impact on receptor activity, making it relevant for determining pathogenicity."
    },
    {
      "step_name": "Sub-step 3a: Basic Controls and Replicates",
      "extracted_paper_info": "Both wild-type EGFR (normal control) and a known activating mutation (positive control) were included. Experiments were performed in triplicate, and results were consistent across replicates.",
      "judgment": "Yes",
      "reasoning": "The inclusion of both normal and positive controls, along with multiple replicates, ensures the validity of the assay setup."
    },
    {
      "step_name": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "Known pathogenic EGFR mutations (e.g., L858R) were used as positive controls alongside benign variants for comparison.",
      "judgment": "Yes",
      "reasoning": "The use of known pathogenic and benign variants as controls allows direct comparison to assess the functional impact of the variant in question."
    },
    {
      "step_name": "Sub-step 4a: Statistical Analyses",
      "extracted_paper_info": "Statistical analysis included t-tests, and p-values were provided for comparisons. OddsPath calculations were performed based on experimental data.",
      "judgment": "Yes",
      "reasoning": "The statistical methods are robust and allow for the calculation of OddsPath values to assess the likelihood of pathogenicity."
    },
    {
      "step_name": "Sub-step 4c: Correlate OddsPath",
      "extracted_paper_info": "OddsPath value calculated for L858R was >18.7, indicating strong evidence supporting its pathogenicity.",
      "judgment": "Yes",
      "reasoning": "The high OddsPath value falls under the 'very_strong' category for PS3 evidence."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The functional evidence for EGFR L858R is very strong (PS3_very_strong) as it demonstrates a clear impact on kinase activity with appropriate controls and statistical analysis."
}